Research findings have suggested a positive correlation between suppressor of cytokine signaling 1 (SOCS1) expression levels and the presence of immune cells such as CD4+ T cells, neutrophils, and myeloid dendritic cells within gliomas, alongside a negative correlation with tumor purity. This evidence concerns the gene SOCS1 and central nervous system cancer.